Systemic and renal hemodynamics after moderate hemodilution with hbocs in anesthetized rabbits

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Caron, Alexis ^a   Menu, Patrick ^a   Faivre Fiorina, Béatrice ^a   Labrude, Pierre ^a   Alayash, Abdu ^b   Vigneron, Claude ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Blood flow; Blood substitutes; Exchange transfusion; Vascular hindrance; Vascular resistance; Viscosity

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN DERIVATIVE; PLASMA SUBSTITUTE;

ANIMAL EXPERIMENT; AORTA FLOW; ARTICLE; BLOOD PRESSURE; BLOOD SUBSTITUTION; BLOOD VISCOSITY; CARDIOVASCULAR AUTOREGULATION; HEART RATE; HEMODILUTION; HEMODYNAMICS; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0033948052     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h1974     Document Type: Article

References (41)

1. Abassi Z, Kotob S, Pieruzzi F, Abouassali M, Keiser HR, Fratantoni JC, and Alayash AI. Effects of polymerization on the hypertensive action of diaspirin cross-linked Hb in rats. J Lab Clin Med 129: 603-610, 1997.
2. Adamson JG and Moore C. Hemolink, an o-raffinose crosslinked hemoglobin-based oxygen carrier. In: Blood Substitutes: Principles, Methods, Products and Clinical Trials, edited by Chang TMS. Basel: Karger Landes, 1998, p. 62-81.
3. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 17: 545-549, 1999.
4. Alkj kr C and Poston L. Effects of pH on vascular tension: which are the important mechanisms? J Vasc Res 33: 347-359, 1996.
5. Bone HG, Schenarts PJ, Fischer SR, McGuire R, Traber LD, and Traber DL. Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic shock. J Appl Physiol 84: 1991-1999, 1998.
6. Caron A, Menu P, Faivre-Fiorina B, Labrude P, Alayash AI, and Vigneron. C. Cardiovascular and hemorheological effects of three chemically-modified human hemoglobin solutions in hemodiluted rabbits. J Appl Physiol 86: 541-548, 1999.
7. Caron A, Menu P, Labrude P, and Vigneron C. Proposition of a technique to assess the vasoactive effects of hemoglobin-based oxygen carrying solutions in vivo: preliminary results in the rabbit aorta. Artif Cells Blood Substit Immobil Biotechnol 26: 293-308, 1998.
8. Chien S. Fåhreus Award Lecture. Hemorheology in disease: pathophysiological significance and therapeutic implications. Clin Hemorheol 1: 419-442, 1981.
9. Cooper JR and Slogoff S. Hemodilution and priming solutions for cardiopulmonary bypass. In: Cardiopulmonary Bypass: Principles and Practice, edited by Gravlec GP, Davis RF, and Utley JR. Baltimore, MD: Williams & Wilkins, 1993, p. 124-137.
10. De Witt C, Schäfer C, von Bismark P, Bolz S-S, and Pohl U. Elevation of plasma viscosity induces sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo. Pflügers Arch 434: 354-361, 1997.
11. Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, and Lemon DD. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16: 672-676, 1998.
12. Faivre B, Menu P, Labrude P, and Vigneron C. Hemoglobin autooxidation/oxidation mechanisms and methemoglobin prevention or reduction processes in the blood stream. Literature review and outline of autooxidation reaction. Artif Cells Blood Substit Immobil Biotechnol 26: 17-26, 1998.
13. Faivre-Fiorina B, Caron A, Fassot C, Fries I, Labrude P, and Vigneron C. Exchange transfusion with a hemoglobin solution in guinea pig: evidence for the presence of hemoglobin inside aortic endothelial cells. Am J Physiol Heart Circ Physiol 276: H766-H770, 1999.
14. Fischer SR, Bone HG, Powell WC, McGuire R, Traber LD, L, and Traber DL. Pyridoxalated hemoglobin polyoxyethylene conjugate does not restore hypoxic pulmonary vasoconstriction in ovine sepsis. Crit Care Med 25: 1551-1559, 1997.
15. Goodnough LT, Scott MG, and Monk TG. Oxygen carriers as blood substitutes. Clin Orthop 357: 89-100, 1998.
16. Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, and Moss GS. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187: 113-122, 1998.
17. Gould SA, Sehgal HR, Sehgal HL, DeWoskin R, and Moss GS. The clinical development of human polymerized hemoglobin. In: Blood Substitutes: Principles, Methods, Products and Clinical Trials, edited by Chang TMS. Basel: Karger Landes, 1998, p. 12-28.
18. Gulati A, Barve A, and Sen AP. Pharmacology of hemoglobin therapeutics. J Lab Clin Med 133: 112-119, 1999.
19. Heymann MA, Payne BD, Hoffman JIE, and Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 20: 55-79, 1977.
20. Hoeks APG, Samijo SK, Brands PJ, and Reneman RS. Noninvasive determination of shear-rate distribution across the arterial lumen. Hypertension 26: 26-33, 1995.
21. Kilbourn RG, De Angelo J, and Bonaventura J. Clinical effects of cell-free hemoglobin, a scavenger of nitric oxide, in septic shock. In: Yearbook of Intensive Care and Emergency Medicine, edited by Vincent JL. Berlin: Springer-Verlag, 1997, p. 230-239.
22. Lehmann ED, Parker JR, Hopkins KD, Taylor MG, and Gosling RG. Validation and reproducibility of pressure-corrected aortic distensibility measurements using pulse-wave-velocity Doppler ultrasound. J Biomed Eng 15: 221-228, 1993.
23. Lieberthal W, Fuhro R, Freedman JE, Toolan G, Loscalzo J, and Valeri CR. o-Raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin. J Pharmacol Exp Ther 288: 1278-1287, 1999.
24. Lipowsky HH and Firrell JC. Microvascular hemodynamics during systemic hemodilution and hemoconcentration. Am J Physiol Heart Circ Physiol 250: H908-H922, 1986.
25. Manner PA, Rubash HE, and Herndon JH. Prospectus. Future trends in transfusion. Clin Orthop 357: 101-115, 1998.
26. Menu P, Longrois D, Faivre B, Donner M, Labrude P, Stoltz J-F, and Vigneron C. Rheological behaviour of red blood cells suspended in hemoglobin solutions. In vitro study comparing dextran-benzene-tetra-carboxylate hemoglobin and plasma expanders. Transfusion 20: 5-16, 1999.
27. Migita R, Gonzales A, Gonzales ML, Vandegriff KD, and Winslow R. Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 82: 1995-2002, 1997.
28. Nelson DJ. Blood and Hemassist (DCLHb): potentially a complementary team. In: Blood Substitutes: Principles, Methods, Products and Clinical, Trials, edited by Chang TMS. Basel: Karger Landes, 1998, p. 39-57.
29. Page TC, Light WR, and Hellums JD. Prediction of microcirculatory oxygen transport by erythrocyte/hemoglobin solution mixtures. Microvasc Res 56: 113-126, 1998.
30. Persson PB. Modulation of the cardiovascular control mechanisms and their interaction. Pharmacol Rev 76: 193-244, 1996.
31. Prouchayret F, Fasan G, Grandgeorge M, Vigneron C, Menu P, and Dellacherie E. A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterisation. In: Blood Substitutes and Oxygen Carriers, edited by Chang TMS. New York: Dekker, 1993, p. 144-147.
32. Rohlfs RJ, Bruner E, Chiu A, Gonzales A, Gonzales ML, Magde D, Magde MD Jr, Vandegriff KD, and Winslow RM. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273: 12128-12134, 1998.
33. 2 affinity. Am J Physiol Heart Circ Physiol 276: H553-H562, 1999.
34. Spahn DR, Leone BJ, Reves JG, and Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of non-oxygen-carrying and oxygen-carrying solutions. Anesth Analg 78: 1000-1021, 1994.
35. Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT, and Schulte am Esch J. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 80: 189-194, 1998.
36. Tsai AG, Friesenecker B, McCarthy M, Sakai M, and Intaglietta M. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol Heart Circ Physiol 275: H2170-H2180, 1998.
37. Tsai AG, Kerger H, and Intaglietta M. Microvascular oxygen distribution: Effects due to free hemoglobin in plasma. In: Blood Substitutes. New Challenges, edited by Winslow RM, Vandegriff KD, and Intaglietta M. Boston, MA: Birkhäuser, 1996, p. 124-131.
38. Walsh JC and Kramer GC. Resuscitation of hypovolemic sheep with hypertonic saline/dextran: the role of dextran. Circ Shock 34: 336-343, 1991.
39. Winslow RM. A physiological basis for the transfusion trigger. In: Perioperative Transfusion Medicine, edited by Spiess BD, Counts R, and Gould SA. Baltimore, MD: Williams & Wilkins, 1998, p. 27-43.
40. Winslow RM and Chapmann KW. Pilot scale preparation of hemoglobin solutions. In: Methods in Enzymology. Hemoglobins: Biochemical and Analytical Methods, edited by Everse J, Vandegriff KD, and Winslow RM. Orlando, FL: Academic, 1994, vol. 231, pt. B, p. 3-16.
41. Winslow RM, Gonzales A, Gonzales ML, Magde M, McCarthy M, Rohlfs RJ, and Vandegriff KD. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 85: 993-1003, 1998.